Rua announces closing date for Director Nominations 2022

Rua Bioscience Limited (NZX: RUA ) advises the closing date for Director nominations is 5:00pm NZST on Tuesday 6 September 2022.

Nominations may only be made by a shareholder entitled to attend and vote at the meeting, and be accompanied by the consent in writing of the person nominated.

Any nominations should be emailed to:

Hamish.white@ruabio.com

Or addressed to:

Director Nominations

Attn: Hamish White

CFO and Company Secretary

Rua Bioscience

PO Box 1387

Gisborne, 4040

Rua takes this opportunity to remind Shareholders that its 2022 Annual Meeting will be held at 10:00am (New Zealand time) on 12 October 2022. The meeting will be a hybrid meeting hosted at Waikanae Surf Club, Grey St, Gisborne and supported by a virtual meeting platform.

Further details for participation and voting online will be included in the formal Notice of Annual Shareholders’ Meeting which will be released prior to the meeting.

ENDS

2022 Director Nominations and Annual Meeting Announcement

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

GEN - Completion of Purchase of Premium Funding Business
Fletcher Building Announces Executive Appointment
WCO - Director independence determination
AIA - welcomes Ngahuia Leighton as 'Future Director'
Mercury announces Executive team changes
Fonterra launches Retail Bond Offer
October 29th Morning Report
BIF adds Zincovery to its investment portfolio
General Capital Resignation of Director
General Capital subsidiary General Finance update